Experimental peptides hold promise for chronic wounds

04/13/2011 | MIT Technology Review online

Scientists at Tufts University have synthesized peptides from collagenase, a bacterial enzyme, to develop agents that could accelerate healing of chronic wounds by promoting angiogenesis. The lead researcher hopes they can advance the experimental agents, which have been tested in animals, to clinical trials. The research appeared in the September issue of Wound Repair and Regeneration.

View Full Article in:

MIT Technology Review online

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN